Cancer II
This book reviews recent breakthroughs in anti-cancer drug discovery. Building on the previous volume in the series, it outlines some of the most significant developments that have occurred in the field in the subsequent period that have led to new drug approvals or promising clinical candidates. Th...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2018.
|
Έκδοση: | 1st ed. 2018. |
Σειρά: | Topics in Medicinal Chemistry,
28 |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Progress in the Discovery of BCR-ABL Kinase Inhibitors for the Treatment of Leukemia
- Small Molecule Inhibitors of the Epidermal Growth Factor Receptor
- Small-Molecule Inhibitors of Bruton's Tyrosine Kinase
- Inhibitors of Vascular Endothelial Growth Factor Receptor
- Inhibitors of the Fibroblast Growth Factor Receptor
- Modulation of the DNA-Damage Response by Inhibitors of the Phosphatidylinositol 3-Kinase Related Kinase (PIKK) Family
- Epigenetic Modulators
- Antibody-Drug Conjugates
- Isoform Selective PI3K Inhibitors for Treating Cancer
- Inhibitors of the Kynurenine Pathway
- Protein-Protein Interaction Inhibitors
- Small Molecule Inhibitors of ALK.